AG
Artal Group’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,467,080
| Closed | -$56.3M | – | 7 |
|
|
2024
Q2 | $56.3M | Buy |
1,467,080
+151,798
| +12% | +$5.82M | 1.43% | 7 |
|
|
2024
Q1 | $77.3M | Sell |
1,315,282
-106,064
| -7% | -$6.23M | 1.97% | 7 |
|
|
2023
Q4 | $85.1M | Sell |
1,421,346
-243,226
| -15% | -$14.6M | 2.83% | 5 |
|
|
2023
Q3 | $63.3M | Buy |
1,664,572
+614,505
| +59% | +$23.4M | 2.71% | 7 |
|
|
2023
Q2 | $95.7M | Sell |
1,050,067
-166,245
| -14% | -$15.1M | 2.96% | 4 |
|
|
2023
Q1 | $80.2M | Buy |
1,216,312
+316,312
| +35% | +$20.9M | 4.77% | 3 |
|
|
2022
Q4 | $46.5M | Sell |
900,000
-100,000
| -10% | -$5.17M | 2.6% | 11 |
|
|
2022
Q3 | $68.3M | Buy |
+1,000,000
| New | +$68.3M | 2.91% | 4 |
|
|
2022
Q2 | – | Sell |
-200,000
| Closed | -$10.2M | – | 133 |
|
|
2022
Q1 | $10.2M | Buy |
+200,000
| New | +$10.2M | 0.43% | 45 |
|
|
2019
Q2 | – | Sell |
-300,000
| Closed | -$5.85M | – | 93 |
|
|
2019
Q1 | $5.85M | Buy |
+300,000
| New | +$5.85M | 0.24% | 56 |
|